Sheaff Brock Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.67M Sell
5,492
-23
-0.4% -$7.74K 0.15% 117
2024
Q4
$1.83M Buy
5,515
+39
+0.7% +$13.2K 0.16% 115
2024
Q3
$1.83M Buy
5,476
+41
+0.8% +$15.6K 0.16% 119
2024
Q2
$2.24M Sell
5,435
-657
-11% -$260K 0.21% 96
2024
Q1
$2.46M Sell
6,092
-261
-4% -$91.8K 0.16% 101
2023
Q4
$1.95M Buy
6,353
+197
+3% +$53.2K 0.15% 107
2023
Q3
$1.49M Sell
6,156
-47
-0.8% -$12K 0.14% 117
2023
Q2
$1.49M Sell
6,203
-25
-0.4% -$5.19K 0.13% 123
2023
Q1
$1.17M Buy
+6,228
New +$1.29M 0.11% 149

Other funds holding MEDP

Sheaff Brock Investment Advisors's MEDP Position: Q1 2025 in Review

Sheaff Brock Investment Advisors reduced its Medpace (MEDP) stake by 0.42% in Q1 2025, selling an estimated $7.74K and leaving 5,492 shares worth $1.67M. The position accounts for 0.15% of the portfolio, ranked #117.

Sheaff Brock Investment Advisors first reported a position in MEDP in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.46M in Q1 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Sheaff Brock Investment Advisors held 5,492 shares of Medpace worth $1.67M as of Q1 2025.
  • Sheaff Brock Investment Advisors sold 23 Medpace shares in Q1 2025, an estimated $7.74K.
  • Medpace made up 0.15% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #117 holding.
  • Sheaff Brock Investment Advisors first reported a position in Medpace in Q1 2023 and has held it in 9 quarters since.
  • Sheaff Brock Investment Advisors's Medpace position peaked at $2.46M in Q1 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.